This inventor holds 1 USPTO granted patent. Top assignee: Siemens Healthcare Diagnostics Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: We-Xing Gan: Innovator in Immunological Assays
Introduction
We-Xing Gan is a notable inventor based in Simi Valley, CA (US). He has made significant contributions to the field of immunology through his innovative patent. His work focuses on the development of methods and reagents for conducting assays for IgE, which are crucial in understanding allergic responses.
Latest Patents
We-Xing Gan holds a patent titled "Galactose-alpha-1,3-galactose-macromolecule conjugates and methods employing same." This patent describes methods and reagents for conducting assays that determine the presence and/or amount of IgE specific for a galactose-alpha-1,3-galactose epitope in a sample. The patent outlines a combination of a sample and a reagent that includes a conjugate of a macromolecule and a compound comprising a galactose-alpha-1,3-galactose epitope. The method involves detecting the presence and/or amount of a complex formed by the binding of IgE to the reagent, which is essential for assessing allergic reactions.
Career Highlights
We-Xing Gan is associated with Siemens Healthcare Diagnostics GmbH, where he applies his expertise in immunological research. His work has contributed to advancements in diagnostic methods that are vital for patient care and treatment.
Collaborations
We-Xing Gan has collaborated with notable colleagues, including Utpal Banik and Ramon A Evangelista. These collaborations have fostered innovation and development in the field of diagnostics.
Conclusion
We-Xing Gan's contributions to immunology through his patent and work at Siemens Healthcare Diagnostics GmbH highlight his role as an influential inventor. His innovative methods for detecting IgE are significant for advancing medical diagnostics and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
